Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1322 issues

Renewing Your Vitrakvi (Larotrectinib) Approval with UnitedHealthcare in Michigan: 2025 Documentation Requirements and Timeline Guide

Answer Box: Quick Start Guide UnitedHealthcare requires annual reauthorization for Vitrakvi (larotrectinib) in Michigan, typically processed through OptumRx. Start the renewal process 3-4 weeks before your current authorization expires. You'll need recent oncology notes showing "no evidence of progressive disease" and updated imaging results. Submit via
6 min read

Renewing Xospata (Gilteritinib) Approval with UnitedHealthcare in Pennsylvania: Complete Timeline and Documentation Guide

Answer Box: Renewing Xospata Coverage with UnitedHealthcare in Pennsylvania To renew Xospata (gilteritinib) approval with UnitedHealthcare in Pennsylvania, start the process 30 days before your current authorization expires. You'll need recent oncology notes showing disease response or stability, updated FLT3 mutation documentation, and evidence of tolerability. Submit through
6 min read

How to Get Synagis (Palivizumab) Covered by UnitedHealthcare in Michigan: Complete Authorization Guide

Answer Box: Getting Synagis Covered by UnitedHealthcare in Michigan UnitedHealthcare covers Synagis (palivizumab) for high-risk infants in Michigan through prior authorization via OptumRx. Call 1-800-310-6826 for prior notification. You'll need cardiology or pulmonology documentation proving your child meets strict criteria: prematurity with chronic lung disease, hemodynamically significant congenital
7 min read

Do You Qualify for Takhzyro Coverage by UnitedHealthcare in Virginia? Decision Tree & Next Steps

Answer Box: Getting Takhzyro Covered by UnitedHealthcare in Virginia You likely qualify for Takhzyro (lanadelumab-flyo) coverage if you have confirmed hereditary angioedema (HAE) with documented C1-INH deficiency and ≥1 attack per month. UnitedHealthcare requires prior authorization through OptumRx with specific lab values and attack documentation. The fastest path: Have your
6 min read

How to Get Strensiq (Asfotase Alfa) Covered by UnitedHealthcare in Michigan: Complete PA Guide, Appeals Timeline & Approval Scripts

Quick Answer: Getting Strensiq Covered by UnitedHealthcare in Michigan UnitedHealthcare requires prior authorization for Strensiq (asfotase alfa) with strict clinical criteria: documented perinatal/infantile or juvenile-onset hypophosphatasia, low alkaline phosphatase levels, ALPL mutation or elevated TNSALP substrates, and prescribing by a specialist. Start by confirming your plan's formulary
5 min read

How Long Does It Take to Get Amvuttra (vutrisiran) Approved by UnitedHealthcare in Ohio? Complete Timeline & Appeals Guide

Answer Box: Getting Amvuttra Approved by UnitedHealthcare in Ohio UnitedHealthcare typically takes 15 business days for standard Amvuttra prior authorization review, or 72 hours for expedited requests. The fastest path: have your specialist submit complete documentation (genetic testing, diagnosis confirmation, prior therapy records) via the UnitedHealthcare Provider Portal. If denied,
5 min read

Work With Your Doctor to Get Acthar Gel Approved by UnitedHealthcare in Pennsylvania: Complete Provider Collaboration Guide

Answer Box: Fast Track to Acthar Gel Approval Getting Acthar Gel covered by UnitedHealthcare in Pennsylvania requires strong provider partnership. Your doctor must submit prior authorization showing failed corticosteroids and medical necessity for your specific condition (infantile spasms, MS exacerbation, or other labeled indication). If denied, you have internal appeals
6 min read

Myths vs. Facts: Getting Amondys 45 (casimersen) Covered by UnitedHealthcare in Illinois - Complete Prior Authorization and Appeals Guide

Answer Box: Getting Amondys 45 (casimersen) Covered by UnitedHealthcare in Illinois Key Facts: UnitedHealthcare requires prior authorization for Amondys 45 with genetic testing proving exon 45-amenable DMD mutation. Illinois residents have strong appeal rights including external review within 4 months of denial. Fastest path: Submit complete PA packet with genetic
6 min read

Get Takhzyro (Lanadelumab-flyo) Covered by UnitedHealthcare in North Carolina: Complete Prior Authorization Guide with Forms and Appeal Scripts

Answer Box: Getting Takhzyro Approved by UnitedHealthcare in North Carolina UnitedHealthcare requires prior authorization for Takhzyro (lanadelumab-flyo) with specific criteria: confirmed HAE diagnosis with C1-INH deficiency, baseline attack rate ≥1 per 4 weeks, and prescribing by an allergist/immunologist. Submit through the UnitedHealthcare Provider Portal with lab results, attack documentation,
6 min read